Stephen L. Garland

597 citations

13 papers · 443 indexed · h-index 10

Cellular and Molecular Neuroscience top 10%
- Neuropeptides and Animal Physiology 3
- Neuroscience and Neuropharmacology Research 2
Molecular Biology
- Receptor Mechanisms and Signaling 5
- Chemical Synthesis and Analysis 3
- Protein Kinase Regulation and GTPase Signaling 2
- Wnt/β-catenin signaling in development and cancer 2
- Glycosylation and Glycoproteins Research 1
Computational Theory and Mathematics top 10%
- Computational Drug Discovery Methods 4
Organic Chemistry
Endocrine and Autonomic Systems

Co-authors: David E. Gloriam Frank E. Blaney Steven M. Foord P. M. Dean Jason Witherington Deirdre M. B. Hickey Martin Saunders Vincent Bordas
Cited by: Cellular and Molecular Neuroscience Molecular Biology Computational Theory and Mathematics
Journals: Biochemical and Biophysical Research Communications (1 paper)Journal of Medicinal Chemistry (2 papers)Chemical Science (1 paper)
Partner nations: United Kingdom Denmark South Sudan

In The Last Decade

Stephen L. Garland

13 papers receiving 430 citations

Peers

Countries citing papers authored by Stephen L. Garland

Since Specialization

Citations

This map shows the geographic impact of Stephen L. Garland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen L. Garland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen L. Garland more than expected).

Fields of papers citing papers by Stephen L. Garland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen L. Garland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen L. Garland. The network helps show where Stephen L. Garland may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stephen L. Garland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen L. Garland Line = papers co-authored together Stephen L. Garland links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	The creation and characterisation of a National Compound Collection: the Royal Society of Chemistry pilot Chemical Science ·David Andrews,Laura M. Broad,Paul Edwards,David Fox,Timothy Gallagher,Stephen L. Garland,Richard Kidd,J. B. Sweeney	2016	5
2	Are GPCRs Still a Source of New Targets? SLAS DISCOVERY ·Stephen L. Garland	2013	116
3	A Ligands View of Target Similarity: Chemogenomic Binding Site- Directed Techniques for Drug Discovery Current Topics in Medicinal Chemistry ·Stephen L. Garland,David E. Gloriam	2011	14
4	An industrial perspective on positive allosteric modulation as a means to discover safe and selective drugs Drug Discovery Today Technologies ·Magalie Rocheville,Stephen L. Garland	2010	9
5	Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74 Biochemical and Biophysical Research Communications ·Philip S. Miller,James Barwell,David R. Poyner,Mark Wigglesworth,Stephen L. Garland,Daniel J Donnelly	2009	31
6	The Discovery of a Selective, Small Molecule Agonist for the Mas-Related Gene X1 Receptor Journal of Medicinal Chemistry ·Berthold Wroblowski,Mark Wigglesworth,Philip Szekeres,G. David Smith,Shahzad S. Rahman,Neville Nicholson,Alison I. Muir,Adrian Hall,Jag Heer,Stephen L. Garland,William J. Coates	2009	11
7	Definition of the G Protein-Coupled Receptor Transmembrane Bundle Binding Pocket and Calculation of Receptor Similarities for Drug Design Journal of Medicinal Chemistry ·David E. Gloriam,Steven M. Foord,Frank E. Blaney,Stephen L. Garland	2009	80
8	The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2 Bioorganic & Medicinal Chemistry Letters ·Pier Luca D’Alessandro,Corrado Corti,Adelheid Roth,Annarosa Ugolini,Anna Sava,Dino Montanari,Federica Bianchi,Stephen L. Garland,Ben Powney,Emma Koppe,Magalie Rocheville,Greg Osborne,Paloma Pérez,Jesús de la Fuente,Maite de los Frailes,Paul W. Smith,Clive L. Branch,D. Nash,Steve P. Watson	2009	13
9	(1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors Bioorganic & Medicinal Chemistry Letters ·Mark J. Bamford,Michael J. Alberti,Nicholas Bailey,Susannah Davies,David K. Dean,Alessandra Gaiba,Stephen L. Garland,John D. Harling,David Jung,Terence A. Panchal,Christopher A. Parr,Jon G.A. Steadman,Andrew K. Takle,James T. Townsend,David M. Wilson,Jason Witherington	2005	30
10	5-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3) Bioorganic & Medicinal Chemistry Letters ·Jason Witherington,Vincent Bordas,Stephen L. Garland,Deirdre M. B. Hickey,Robert J. Ife,John Liddle,Martin Saunders,David G. Smith,Robert W. Ward	2003	95
11	5‐Aryl‐pyrazolo[3,4‐b]pyridines: Potent Inhibitors of Glycogen Synthase Kinase‐3 (GSK‐3). ChemInform ·Jason Witherington,Vincent Bordas,Stephen L. Garland,Deirdre M. B. Hickey,Robert J. Ife,John Liddle,Martin Saunders,David G. Smith,Robert W. Ward	2003	1
12	Design criteria for molecular mimics of fragments of the β-turn. 2. Cα–Cβ bond vector analysis Journal of Computer-Aided Molecular Design ·Stephen L. Garland,P. M. Dean	1999	14
13	Design criteria for molecular mimics of fragments of the β-turn. 1. Cα atom analysis Journal of Computer-Aided Molecular Design ·Stephen L. Garland,P. M. Dean	1999	24

About Stephen L. Garland

Stephen L. Garland is a scholar working on Computational Theory and Mathematics, Cellular and Molecular Neuroscience and Molecular Biology, having authored 13 papers that have together received 443 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (5 papers), Computational Drug Discovery Methods (4 papers), Chemical Synthesis and Analysis (3 papers), Neuropeptides and Animal Physiology (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (174 citations), Molecular Biology (323 citations) and Computational Theory and Mathematics (58 citations). Stephen L. Garland has collaborated with scholars based in United Kingdom, Denmark and South Sudan. Frequent co-authors include David E. Gloriam, Frank E. Blaney, Steven M. Foord, P. M. Dean, Jason Witherington, Deirdre M. B. Hickey, Martin Saunders, Vincent Bordas, John Liddle and Robert J. Ife. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Chemical Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact